Evidence mapPaperPMID 35505465Full record

SynthesisAlimentary pharmacology & therapeutics2022

Systematic review-pancreatic involvement in inflammatory bowel disease.

Sara Massironi, Ilaria Fanetti, Chiara Viganò, Lorena Pirola, Maria Fichera, Laura Cristoferi, Gabriele Capurso, Pietro Invernizzi, Silvio Danese

Open access · hybridAbstract readSystematic Review
In one paragraph

Synthesis in Alimentary pharmacology & therapeutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 4 pooled it
8.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 4 syntheses or guidelines pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. Pooled it
  5. Unique causes of exocrine pancreatic insufficiency: When to consider pancreatic enzyme supplementation: A narrative review.Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition · 2026
    Review
  6. Article
  7. Pancreatic Hyperenzymemia in Inflammatory Bowel Disease: Clinical Characterization and Outcomes from the European PANDORA Registry.Pathophysiology : the official journal of the International Society for Pathophysiology · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Autoimmune Pancreatitis: A Review.Journal of clinical medicine · 2025
    Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Sara MassironiDepartment of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.ORCID 0000-0003-3214-8192
Ilaria FanettiGastroenterology and Endoscopy Unit, ASST Ovest Milanese, Legnano Hospital, Legnano, Italy.
Chiara ViganòDepartment of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
Lorena PirolaDepartment of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
Maria FicheraDepartment of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
Laura CristoferiDepartment of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
Gabriele CapursoPancreas Translational & Clinical Research Center, Pancreato-Biliary Endoscopy & Endosonography Division, San Raffaele Scientific Institute IRCCS, Milan, Italy.
Pietro InvernizziDepartment of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.ORCID 0000-0003-3262-1998
Silvio DaneseGastroenterology and Endoscopy, IRCCS Ospedale San Raffaele and Vita-Salute San Raffaele University, Milan, Italy.ORCID 0000-0001-7341-1351
Azienda Ospedaliera San Gerardo · ITVita-Salute San Raffaele University · ITAzienda Ospedaliera Ospedale Civile di Legnano · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInflammatory bowel disease (IBD) is a chronic inflammatory immune-mediated disorder of the gut with frequent extra-intestinal complications. Pancreatic involvement in IBD is not uncommon and comprises a heterogeneous group of conditions, including acute pancreatitis (AP), chronic pancreatitis (CP), autoimmune pancreatitis (AIP) and pancreatic exocrine insufficiency (PEI); however, data on such an association remain sparse and heterogeneous.

methodPubMed/MEDLINE and EMBASE databases were searched for studies investigating pancreatic involvement in patients with IBD.

resultsFour thousand one hundred and twenty-one records were identified and 547 screened; finally, 124 studies were included in the review. AP is the most frequent pancreatic manifestation in IBD; the majority of AP cases in IBD are due to gallstones and drugs but cases of idiopathic AP are increasingly reported. AIP is a rare disease, but a strong association with IBD has been demonstrated, especially for type 2 and ulcerative colitis. The pathogenetic link between IBD and AIP remains unclear, but an immune-mediated pathway seems plausible. An association between CP and PEI with IBD has also been suggested, but data are to date scarce and conflicting.

conclusionThis is the first systematic review of the association between IBD and pancreatic diseases. Gallstones and drugs should be considered the most probable causes of AP in IBD, with type 2 AIP also being possible.

Indexed as

Autoimmune DiseasesColitis, UlcerativeExocrine Pancreatic InsufficiencyGallstonesInflammatory Bowel DiseasesPancreatitis, ChronicAcute DiseaseChronic DiseaseHumans

Identifiers

PMID35505465
PMCPMC9322673
OpenAlexW4225411419

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.